The University of Chicago Header Logo

Connection

Rolf Barth to Kidney Diseases

This is a "connection" page, showing publications Rolf Barth has written about Kidney Diseases.
Connection Strength

0.734
  1. Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation. 2014 Jan 27; 97(2):133-7.
    View in: PubMed
    Score: 0.376
  2. Impact of Renal Replacement Therapy on Rejection among Liver Transplant Recipients. Prog Transplant. 2023 Dec; 33(4):348-355.
    View in: PubMed
    Score: 0.186
  3. Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction. Dig Dis Sci. 2015 Nov; 60(11):3491-4.
    View in: PubMed
    Score: 0.104
  4. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol. 2005 Sep; 16(9):2732-45.
    View in: PubMed
    Score: 0.052
  5. The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant. 2008 Nov; 8(11):2316-24.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.